Mutations in 5 genes encoding desmosome proteins, namely PKP2 (plakophilin 2), JUP (junction protein plakoglobin), DSP (desmoplakin), DSC2 (desmocollin 2), and DSG2 (desmoglien 2), are the most common known causes of ACM. [7] [8] [9] [10] [11] [12] Homozygous mutations in DSP and JUP cause ACM occurring in conjunction with palmoplantar keratosis, wooly hair, and alopecia, which are referred to as cardiocutaneous syndromes. 7, 8, 13 Mutations in several others genes, including PLN and LMNA, encoding phospholamban and lamin A/C, respectively, also have been implicated in ACM. 14, 15 Desmosomes are components of the intercalated discs (IDs), which are primarily present in the epithelial cells and involved in cell-to-cell attachment, mechanotransduction, and mechanical integrity of the tissue. [16] [17] [18] [19] The mechanisms by which mutations in desmosome proteins lead to ACM and its typical phenotypes of ventricular arrhythmias, excess fibroadipocytes, or cardiocutaneous syndromes are not fully understood. Deletion of the Dsp gene exclusively in cardiac myocytes in mice leads to cardiac dysfunction, premature death, and mild fibroadipogenesis. 19 However, cardiac arrhythmias in the myocyte-specific Dsp-deficient mice occur in the context of cardiac dysfunction but not independent of cardiac dysfunction. 19 The arrhythmic phenotype in the cardiac myocyte-specific deletion of Dsp is in contrast to the human ACM, where cardiac arrhythmias are often the early manifestations, occurring before and independent of cardiac dysfunction. [2] [3] [4] The dissociation of early cardiac arrhythmias and function might simply reflect potential differential effects of the desmosome protein mutations in stabilizing the ion channel at the IDs and maintaining mechanical integrity of the myocardium. Alternatively, it may indicate possible involvement of nonmyocyte cells in the pathogenesis of early cardiac arrhythmias in ACM.
Desmosome proteins are known to be expressed primarily in cardiac myocytes and epithelial cells. They are also expressed, albeit at lower levels, in the nonmyocyte cardiac cells, such as the mesenchymal cells and fibroadipocyte progenitors. 20, 21 Cells expressing the mutant desmosome proteins, whether myocytes or nonmyocyte cells, are expected to be involved in the pathogenesis of ACM. 20, 21 The publicly available RNA sequencing and microarray databases include Cspg4 (chondroitin sulfate proteoglycan 4 
Novelty and Significance
What Is Known?
• Arrhythmogenic cardiomyopathy (ACM) is a primary disease of myocardium caused mostly by mutations in genes encoding desmosome proteins.
• Ventricular arrhythmias are the cardinal manifestation of ACM, occurring early and before cardiac dysfunction.
• Altered functions of ion channels in cardiac myocytes are implicated in the pathogenesis of ventricular arrhythmias in ACM.
• A subset of ACM manifests with skin abnormalities occurring in conjunction with cardiomyopathy and is referred to as cardiocutaneous syndrome.
What New Information Does This Article Contribute?
• CSPG4 (chondroitin sulfate proteoglycan 4) is a marker for cardiac conduction system, tagging a subset of cardiac conduction system cells.
• Cardiac cells expressing CSPG4 also express selected desmosome proteins and ion channels.
• Postnatal (day 21) inducible conditional deletion of Dsp gene, encoding desmoplakin, under the transcriptional regulation of the Cspg4 locus, that is, in cells expressing CSPG4, leads to early ventricular and atrial arrhythmias and premature death in the presence of a preserved left ventricular systolic function, as observed in human ACM.
• Deletion of Dsp in the CSPG4 pos cells also leads to progressive alopecia and severe palmoplantar keratosis, as observed in cardiocutaneous syndromes in humans.
The findings delineate a cellular basis for early ventricular arrhythmias in ACM-an important cause of sudden cardiac death in the young, particularly in athletes. The present findings along with the previous data point to participation of multiple cell types in the pathogenesis of ACM phenotypes, with CSPG4 pos cells contributing to early cardiac arrhythmias, fibroadipocyte progenitor cells to fibroadiposis, and cardiac myocytes to cardiac dysfunction and heart failure. Delineation of the molecular and cellular basis of ACM could offer the opportunities to identify new diagnostic tools and novel therapeutic targets in ACM.
transcript) among those expressed in the cardiac conduction system (CCS), including the Purkinje fibers and the atrioventricular node. 22, 23 The CCS, sharing an embryonic origin with cardiac myocytes, also expresses desmosome proteins. 24, 25 CSPG4 is also expressed in the keratinocytes and hair follicle cells, which are known to express DSP. 26, 27 Therefore, CSPG4, along with desmosome proteins, might serve as a shared molecular link between early cardiac arrhythmias and the skin phenotype in the cardiocutaneous syndromes. Thus, we determined the phenotypic consequences of deletion of Dsp under the transcriptional regulation of the Cspg4 locus.
Methods
An expanded Methods section is provided as Online Data Supplement.
Studies in the animal models conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health and was approved by the Institutional Animal Care and Use Committee. Human tissue use was approved by the institutional review board.
Histology (Hematoxylin and Eosin, Masson Trichrome, and Oil Red O Staining), Immunohistochemistry, and Immunofluorescence
These techniques were performed as published. 18, 20, 28 Custom-made and commercially available antibodies were used to detect expression of the proteins of interest, including CSPG4 and DSP in isolated cardiac myocytes, nonmyocyte cardiac cells, and myocardial sections (Online Table I ).
Isolation of Human and Mouse Adult Myocytes and Nonmyocyte Cardiac Cells
Cardiac myocyte-depleted cell fraction was obtained by collagenase type 2 digestion as published. 20 The tissue samples were digested with collagenase, filtered through a 40-μm cell strainer, and the cells were precipitated by centrifugation. The pelleted cells were resuspended in a complete medium in the presence of antibiotics and plated on plates coated with 0.1% gelatin.
Cells expressing CSPG4 were isolated from myocyte-depleted cardiac cells by flow cytometry and fluorescence-activated cell sorting (FACS), as described, except for using a custom-made rabbit anti-CSPG4 antibody. 
Cspg4-DsRed.T1 Reporter Mice
Cspg4-DsRed.T1 is a bacterial artificial chromosome transgenic reporter mouse line that expresses a red fluorescence protein variant, Ds-Red.T1, under the transcriptional regulation of the Cspg4 locus (stock number: 008241, Jackson Laboratory).
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Cspg4-Cre/Esr1*:Dsp W/F and Cspg4-Cre/ Esr1*:Dsp F/F Mice These mice were generated on crossing of Dsp floxed mice with the Cspg4-Cre/Esr1* deleter mice. 19, 30 The Dsp gene was deleted in 21-day old mice on intraperitoneal injection of tamoxifen.
Quantitative Polymerase Chain Reaction
Quantitative polymerase chain reaction was performed as published and the relative normalized values (2^-∆∆ method, shown as relative to the WT [wild-type] mice) were used to compare the transcript levels.
18,28

Immunoblotting
Immunoblotting was performed as published.
18,28
Apoptosis
Apoptosis was detected in thin myocardial section by TUNEL (terminal deoxynucleotidyl transferase dUTP nick-end labeling) assay, as published. 19, 31 The number of TUNEL-positive cells was quantified in ≈20 000 cells per mouse and in 6 mice per group. 
Echocardiography
Electrocardiography and Electrophysiology
Surface ECG and heart rate were recorded after insertion of 29-gauge needle electrodes subcutaneously into the forelimbs and connecting the leads to an Animal Bio Amp, PowerLab, and the LabChart7 software.
Electrophysiology studies were performed in isoflurane-anesthetized mice at temperature between 36 and 37°C. Intracardiac bipolar atrial and ventricular electrograms were obtained using a 1.1F octapolar catheter (EPR-800; Millar Instruments), as described. 33, 34 Electrophysiology pacing protocols, including single, double, and burst ventricular pacing protocols, were used for ventricular tachycardia induction at baseline and after injection of isoproterenol (3 mg/kg IP). The atrial stimulation protocol to evaluate inducibility of atrial fibrillation was performed with incremental atrial pacing, as described. 34 All pacing protocols were performed a maximum of 3×. Nonsustained and sustained ventricular tachycardia was defined as reproducible (at least twice) ectopic ventricular rhythms lasting 4 to 9 rapid consecutive ventricular beats and ≥10 beats, respectively. Atrial fibrillation was defined as reproducible rapid and fragmented atrial electrograms with irregular ventricular response for ≥1 second.
Statistical Analysis
Data that followed a Gaussian distribution pattern were presented as mean±SD and were compared between 2 groups by t test and among multiple groups by ANOVA followed by post hoc pairwise comparisons. Otherwise, data were presented as the median values and compared by Kruskall-Wallis test, as were the categorical data.
Results
CSPG4 Is Expressed in CCS and Skin Keratinocytes
To corroborate the transcriptomic data detecting the Cspg4 transcripts in the heart, nonmyocyte fraction of cardiac cells was isolated and sorted against a custom-made anti-CSPG4 antibody. FACS analysis showed that ≈5.6±3.3% of cardiac nonmyocyte cells expressed CSPG4 ( Figure 1A ; Online Figure I ). To further corroborate detection of the Cspg4 transcripts in the CCS, coexpression of CSPG4 and CNTN2 (contactin 2)-an established CCS marker-in cardiac cells was analyzed by FACS and immunostaining. CSPG4 and CNTN2 were coexpressed in a subset of isolated cardiac nonmyocyte cells and about two third of cells expressing CSPG4 also expressed CNTN2 (Figure 1B and 1C ; Online Figure I ).
To detect expression and localization of CSPG4 in the heart, thin myocardial sections from adult mice were stained with a custom-made antibody against CSPG4. Expression of CSPG4 was detected in the atrioventricular node and the bundle branches, which were identified by the expression of CNTN2 or GJA5 (connexin 40)-2 well-established CCS markers ( Figure 1D through 1G) . 22, 35 To corroborate the immunofluorescence data, thin myocardial sections from the Cspg4-DsRed.T1 reporter mouse hearts were examined under fluorescence microscopy. DsRed.T1 expression, reflecting Cspg4 locus transcriptional activity and hence an antibody-independent surrogate for CSPG4, was detected in the atrioventricular node ( Figure 1H ). Ds-Red.T.1 expression and localization in the myocardial sections was largely consistent with the detection of CSPG4 expression in the CCS by immunofluorescence staining, albeit less pronounced. Colocalization of CSPG4 and CNTN2 was partial, suggesting expression of CSPG4 in a subset of the CCS cells and cellular heterogeneity of the CCS. In addition to the CCS, CSPG4 was also expressed in a subset of cells within the interstitial tissue in the myocardium, likely representing capillary mural cells or pericytes ( Figure 1I ). Notably, expression of CSPG4 was not detected in the ventricular myocytes both by immunostaining and by examination of myocardial sections from the Cspg4-DsRed.T1 reporter mice ( Figure 1H and 1I).
Given the detection of the CSPG4 in capillary mural cells and its known expression in a subset of pericytes, 36 isolated cardiac nonmyocyte cells were costained for CSPG4 and PDGFRB (platelet-derived growth factor receptor beta) proteins, the latter a marker for pericytes. 37 Expressions of the CSPG4 and PDGFRB proteins were detected in 8.1±10.6% and 2.6±3.3% of the isolated cardiac nonmyocyte cells, respectively (Online Figure IIA) . Only ≈10% of cells expressing PDGFRB also expressed CSPG4. In addition, CSPG4 was not expressed in the endothelial cells, marked by the expression of PECAM1 (platelet endothelial cell adhesion molecule 1; Online Figure IIB ).
CSPG4 was also strongly expressed in murine back skin, as detected by immunoblotting and immunofluorescence staining ( Figure 1J and 1K). Its expression was predominantly localized to epidermal keratinocytes in the interfollicular epidermis and hair follicles ( Figure 1K ). As expected, DSP was also expressed throughout the epidermis ( Figure 1K ). To further corroborate the findings, independent of the antibody performance, expression of CSPG4 was analyzed in the Cspg4-DsRed.T1 mice where DS-RedT.1 reporter protein serves as a surrogate for the expression of CSPG4 protein. DsRed.T1 expression was detected in the skin, predominantly in the interfollicular epidermis and hair follicles (Online Figure III) . 
Selected Ion Channel and Desmosome Proteins Are Expressed in Cardiac CSPG4
pos Cells
Given that CSPG4 also tagged the CCS, expression of selected ion channel genes was analyzed in the CSPG4 pos cells isolated from the heart by FACS. Immunofluorescence staining detected expression of SCN5A (sodium voltage-gated channel α subunit 5), KCNQ1 (potassium voltage-gated channel subfamily Q member 1), KCNH2 (potassium voltage-gated channel subfamily H member 2 or HERG), and KCNE1 (potassium voltage-gated channel subfamily E regulatory subunit 1) in the cardiac CSPG4 pos cells (Figure 2A ). To determine whether cardiac CSPG4 pos cells express desmosome proteins and hence contribute to the pathogenesis of ACM caused by desmosome protein mutations, mouse cardiac nonmyocyte cell fraction was sorted against an anti-CSPG4 antibody, and the isolated cells were stained for the coexpression of selected desmosome proteins and CSPG4. Figure 2B illustrates expression of selected desmosome proteins, including DSP, JUP, and PKP2, along with the expression of CSPG4 in the FACS-isolated murine cardiac nonmyocyte cells.
To extend the findings to the CSPG4 pos cells isolated from the human hearts, cardiac nonmyocyte cell fraction was isolated from the explanted human hearts not used for cardiac transplantation and costained with antibodies against CSPG4 and selected desmosome proteins. As observed in CSPG4 pos cells isolated from the mouse heart, desmosome proteins were also coexpressed with CSPG4 in the isolated human cardiac nonmyocyte cells ( Figure 2C ).
To complement the results of immunofluorescence studies, RNA was extracted from isolated cardiac CSPG4 pos cells and the transcript levels of selected genes encoding desmosome and ion channel proteins were quantified by quantitative polymerase chain reaction. The results verified expression of Dsp, Jup, Pkp2, Kcnq1, Kcnh2, and Kcne1 in the isolated CSPG4 pos cells, albeit the transcripts were less abundant than the corresponding transcripts in the isolated cardiac myocytes ( Figure 2D) .
Finally, to determine whether cardiac myocytes express CSPG4, isolated cardiac myocytes were costained for cardiac ACTN2 (actinin α2) and CSPG4. As shown (Online Figure IVA) , CSPG4 was not expressed in cardiac myocytes. Likewise, transcript levels of Myh6 and Actc1 were quantified by quantitative polymerase chain reaction in isolated cardiac CSPG4 pos cells. Myh6 and Actc1 transcript levels comprised approximately <0.01% and 0.04% of those in cardiac myocytes (Online Figure IVB) . To determine whether deletion of Dsp in CSPG4 pos cells induces a cardiac or skin phenotype, one or both copies of the Dsp were deleted postnatally (day 21) under transcriptional regulation of the Cspg4 locus (Online Figure V) . The approach of postnatal deletion reduced potential confounding effects, resulting from the transcriptional activity of the Cspg4 locus in other cell types during cardiac development. Recombination efficiency of the Dsp gene in the heart was low (1.63% in the Cspg4-Cre/Esr1*:Dsp F/F mice), which is consistent with the small number of cardiac CSPG4 pos cells and the absence of transcriptional activity of the Cspg4 locus in other cardiac cells ( Figure 3A) . Recombination efficiency, however, was almost 100% in the skin in the Cspg4-Cre/Esr1*:Dsp F/F mice, in accord with the expression of CSPG4 in the keratinocytes and their abundance in the skin ( Figure 3B ).
Postnatal In Vivo
To further confirm deletion of the Dsp gene in the CSPG4 pos cells, expression of Dsp transcript and DSP protein were detected in the isolated cardiac CSPG4 pos cells. Although DSP was expressed in the CSPG4 pos cells isolated from the WT mouse hearts, it was not detectable in the CSPG4 pos cells isolated from the Cspg4-Cre/Esr1*:Dsp F/F mouse hearts ( Figure 3C ). Likewise, Dsp transcript levels were significantly lower in Cspg4-Cre/Esr1*:Dsp F/F mice when compared with WT (46.3±10.0%; Figure 3D ).
To exclude possible fortuitous deletion of Dsp gene in cardiac myocytes, expression and localization of DSP protein were analyzed in the whole heart and isolated cardiac myocytes, respectively. Dsp transcript levels were unchanged in cardiac myocytes isolated from the Cspg4-Cre/Esr1*:Dsp To investigate the cause of premature death, cardiac rhythm was monitored for 4 hours per day for 3 consecutive days (a total of 12 hours) in each mouse. Implantable telemetric monitoring could not be performed because of a smaller body weight of the Cspg4-Cre/Esr1*:Dsp F/F mice, which hindered implantation of radio transmitter (Online Figure VI) . During cardiac rhythm monitoring, the Cspg4-Cre/Esr1*:Dsp F/F mice exhibited spontaneous high-grade atrioventricular block, intermittent atrial fibrillation, and runs of nonsustained ventricular tachycardia ( Figure 4B ). ECG and rhythm phenotypes in the WT and Cspg4-Cre/Esr1*:Dsp W/F were unremarkable. To further analyze the propensity of the Dsp-deficient mice to develop cardiac arrhythmias, 1-to 3-months-old WT (n=7) and Cspg4-Cre/Esr1*:Dsp F/F (n=10) mice underwent in vivo electrophysiology studies. Cspg4-Cre/Esr1*:Dsp W/F mice were not studied because they had normal survival and did not show rhythm abnormalities during cardiac rhythm monitoring. Heart rates at the baseline and conduction intervals were not significantly different between WT and Cspg4-Cre/ December 8, 2017 Figure 3 . Fidelity of the approach to deleting the Dsp (desmoplakin) gene specifically in the CSPG4 pos (chondroitin sulfate proteoglycan 4) cells. A and B, Recombination efficiency in the heart and skin tissues. The floxed, wild-type (WT), and recombined alleles are identified by size. Recombination efficiency was low in the heart and high in the skin in keeping with the small and high number of cells expressing CSPG4 in the heart and skin, respectively. C, Absence of DSP expression in the CSPG4 pos cells isolated from the Cspg4-Cre/Esr1*:Dsp F/F mouse hearts and the corresponding WT control. The upper immunofluorescence panel shows expression of CSPG4, the middle DSP, and the lower overlay of the 2 panels in the experimental groups. As shown, DSP was expressed in the CSPG4 pos cells isolated from the WT but not from the mice obtained before death. The mice exhibited progressive sinus bradycardia, J point elevation, junctional escape beats, and advanced third-degree AV block followed by asystole before death. December 8, 2017
ST elevations and progressive heart block preceding death ( Figure 4D ).
Normal Cardiac Function in the Cspg4-Cre/ Esr1*:Dsp F/F Mice
To determine whether cardiac arrhythmias on deletion of Dsp in the CSPG4 pos cells were associated with cardiac dysfunction or were independent of it, echocardiography was performed in 3-month-old Cspg4-Cre/Esr1*:Dsp F/F mice and age-and sex-matched control WT mice. In addition, echocardiography was also performed in 6-to 10-month-old Cspg4-Cre/ Esr1*:Dsp W/F along with matching WT controls. The results, shown in Online Tables III and IV, Figure VII) .
Absence of Excess Fibroadipocytes in the Heart
Progressive Alopecia and Palmo/Plantar Keratosis in the Cspg4-Cre/Esr1*:Dsp F/F Mice
The Cspg4-Cre/Esr1*:Dsp F/F mice exhibited progressive alopecia starting 2 weeks after induced deletion of the Dsp gene, which progressed to alopecia totalis by 4 to 6 months of age ( Figure 6A) . Likewise, the mice exhibited severe palmar and plantar keratosis ( Figure 6B ) resembling the skin phenotypes of human patients with Cavajal and Naxos syndromes, caused by homozygous deletion of DSP and JUP, respectively. 7, 8, 38 Immunofluorescence staining of skin section showed effective ablation of DSP in the keratinocytes ( Figure 6C ), consistent with a high recombination efficiency ( Figure 3B ). The Cspg4-Cre/Esr1*:Dsp W/F mice did not show similar skin phenotypes ≤1 year of age.
To delineate the mechanistic basis of alopecia and keratosis and given the role of CSPG4 pos cells in renewal of the epidermal keratinocytes, 26,27,39 skin tissue was stained for markers of cell proliferation, differentiation, inflammation, and apoptosis. Histological analysis of the skin of Cspg4-Cre/Esr1*:Dsp F/F mice revealed a defect in epidermal sheet formation and a hyperplastic interfollicular epidermis ( Figure 6D ). The Dsp-deficient mice displayed a hyperproliferative and thickened interfollicular epidermal basal layer, as demonstrated by immunohistochemical staining for the MKI67 (proliferation marker Ki67) and basal layer marker KRT14 (keratin 14), TP53 (tumor protein 53), and TP63 (tumor protein 63; Figure 6D ). To determine whether epidermal differentiation was effected by Dsp deficiency, skin sections were stained for early differentiation markers KRT1 and KRT6 and terminal differentiation marker PRDM1 (PR/SET domain 1). 40 Staining for KRT1, KRT6, and PRDM1 showed strong suprabasal immunoreactivity ( Figure 6D ). In line with the observed hyperproliferative phenotype, sebaceous glands were enlarged in the skin of Dsp-deficient mice, as assessed by staining for FAS (fatty acid synthase)-a sebocyte marker (Online Figure VIII) .
Immunohistochemical staining of skin section for the expression of apoptosis markers CASP3 (caspase 3) and BCL2 (B-cell lymphoma 2; apoptosis regulator) showed no detectable changes in BCL2 and CASP3 expressions (Online Figure VIII) . Similarly, markers of inflammation, including ADGRE4 (adhesion G protein-coupled receptor F4), formerly known as F4/80-a macrophage marker-and TNFα (tumor necrosis factor-α)-a proinflammatory cytokine-were unchanged (Online Figure VIII) . Likewise, the number of bone marrow-derived hematopoietic cells, identified by the expression of PTPRC (protein tyrosine phosphatase, receptor type C), formerly known as CD45, in the skin were unchanged.
Finally, to determine whether deficiency of DSP in skin keratinocytes impacted localization of JUP, thin skin sections from WT and Cspg4-Cre/Esr1*:Dsp F/F mice were costained for coexpression of KRT14 and JUP. The results showed unaltered localization of JUP in the skin keratinocytes, albeit JUP expression was markedly increased consistent 
Discussion
Cardiac arrhythmias-the cardinal manifestations of ACMare typically the first manifestations, occurring before and in the absence of cardiac dysfunction. 1 Cardiac arrhythmias are considered to be the consequence of expression of the mutant or deficiency of the desmosome protein in cardiac myocytes. Experimentally, deletion of genes encoding desmosome proteins in cardiac myocytes in mice leads to cardiac dysfunction but not early cardiac arrhythmias. 19 Cardiac arrhythmias in such models occur concurrently with cardiac dysfunction. 19 The findings of the present study suggest a noncardiac myocyte origin of the early cardiac arrhythmias in ACM. The findings specifically implicate an origin from cells expressing CSPG4, likely the CCS, which are also known to express desmosome proteins and, hence, are expected to be affected in human ACM. 24, 25 Accordingly, deletion of the Dsp gene, specifically in the CSPG4 pos cells, which also tags the CCS in the heart, in addition to the capillary mural and neuroglial cells, leads to spontaneous atrial and ventricular arrhythmias and premature mortality. 22, 23 Notably, these arrhythmias occur in the presence of a normal cardiac function and absence of fibroadiposis. The phenotype simulates the early cardiac arrhythmias in humans with ACM and, hence, implicates a distinct cellular basis for early cardiac arrhythmias in ACM.
In accord with the expression of CSPG4 and DSP in skin progenitors and their role in keratinocyte renewal, 26, 27, 41 deletion of Dsp specifically in the CSPG4 pos cells also led to enhanced proliferation and impaired terminal differentiation of keratinocytes and the clinical phenotype of alopecia totalis and severe keratosis. Strong suprabasal immunoreactivity against KRT1, KRT6, and BLIMP1 (beta-interferon gene positiveregulatory domain I binding factor) suggested initiation but delayed terminal differentiation of keratinocytes in the skin of Dsp-deficient mice. 40 In line with earlier studies, Dsp deficiency in the epidermal basal layer caused defects in epidermal sheet formation on mechanical stress. 42 However, no evidence for an inflammatory infiltrate or apoptosis was found. Increased expression of TP53, in the absence of apoptotic epidermal keratinocytes, is in accord with a hyperproliferative epidermal basal layer and impaired (or absent) terminal differentiation in the skin of Cspg4-Cre/Esr1*:Dsp F/F mice. 43 The observed phenotype, resembling those found in human patients with Carvajal syndrome and Naxos disease, 7, 8, 38 defines a cellular basis for the skin phenotype in cardiocutaneous syndromes.
Whereas ventricular and atrial arrhythmias are known phenotypic features of ACM, atrioventricular block is not a recognized phenotype. Conduction defect in human ACM typically manifests as an epsilon wave, which also has been reported in PKP2 deficiency. 44 Atrioventricular block was observed only in the Cspg4-Cre/Esr1*:Dsp F/F mice but not in heterozygous deletion of DSP, which is the common genotype in human ACM. Similarly, the relevance of progressive bradycardia and atrioventricular block preceding death in the DSPdeficient mice to human ACM is unclear. These data along with the previous data point to the role of DSP in regulating cardiac rhythm and conduction. 45 Studies in human patients with homozygous deficiency of DSP would be required to determine whether atrioventricular block is also a phenotypic feature of human patients with ACM. Likewise, it is unclear whether atrial fibrillation-a known phenotype of ACM 5, 6 also occurs before and in the absence of cardiac dysfunction in patients with ACM. In addition, the findings in the Cspg4-Cre/Esr1*:Dsp F/F might be pertinent only to a subset of human patients with the cardiocutaneous syndromes caused by DSP deficiency but not those caused by missense mutations or those caused by the heterozygous mutations. Finally, phenotypic differences between human ACM and the mouse model are inherent to the model systems, which provide valuable insight into the pathogenesis of the phenotype but typically do not recapitulate the human disease.
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CSPG4 is also expressed in the mural capillary cells or pericytes and neuroglial cells, which might be a cell source of fibroadipocytes in ACM. The findings show that deletion of Dsp in the CSPG4 pos cells did not result in excess fibroadipocytes in the heart, hence excluding these cells, or at least the subset that express CSPG4, as the potential sources of the pathological hallmark of ACM.
The new findings, in conjunction with the previous data, suggest a potential multicellular origin of the ACM phenotypes. Accordingly, expression of the mutant proteins, or the deficiency thereof, in cardiac myocyte leads mainly to cardiac dysfunction, 19 whereas the effect in cardiac fibroadipocyte progenitors is excess fibroadipocytes 20 and that in CSPG4 pos cells cardiac arrhythmias. The multicellular basis of ACM is consistent with the molecular genetics of ACM because the causal mutations are germ line mutations affecting cell lineages that express the desmosome proteins. Accordingly, each cardiac cell type, expressing the mutant desmosome protein, mainly contributes to a specific phenotype; cardiac myocytes to cardiac dysfunction, CCS to early cardiac arrhythmias, and fibroadipocyte progenitors to excess fibroadipocytes. Several lines of data support fidelity of the Cspg4-Cre mediated deletion of Dsp gene and intactness of expression of DSP in cardiac myocytes. First, by design, Dsp was deleted at postnatal day 21 to avoid potential deletion of Dsp in other cell types in which the Cspg4 locus might be transcriptionally active during the development. In support of the experimental approach, the Cspg4 locus, which drives expression of the Cre recombinase, is not transcriptionally active in adult cardiac myocytes-a prerequisite for the deletion of the Dsp gene. Accordingly, CSPG4 was not expressed in cardiac myocytes, and Dsp transcript levels were unchanged in the isolated adult cardiac myocytes. Likewise, DSP protein was expressed and localized to the IDs in the Cspg4-Cre/Esr1*:Dsp F/F mice. In addition, the DsRed.T1 reporter protein-a surrogate for the transcriptional activity of the Cspg4 locus in the Cspg4:DsRed. T1 reporter mice-was not detected in cardiac myocytes. The DsRed.T1 protein, however, seems to be insoluble and often difficult to detect. Therefore, it might not be the most reliable marker. Therefore, the data were complemented with immunofluorescence staining of isolated cardiac myocytes using custom-made anti-CSPG4 antibodies, which did not show expression of CSPG4 in cardiac myocytes. Finally, the Cspg4-Cre/Esr1*:Dsp F/F mice did not show evidence of cardiac dysfunction, which would be expected on deletion of Dsp in cardiac myocytes, as reported previously. 19 Consequently, the data indicate that cardiac arrhythmias and conduction defects in the Cspg4-Cre/Esr1*:Dsp F/F mice are independent of cardiac myocytes and cardiac dysfunction but rather reflective of deletion of the Dsp gene in nonmyocyte cells in the heart, specifically the CCS.
CSPG4 is also expressed in brain tissue and is a marker for neuroglial type II cells. 47 However, neuroglial cells are not known to express desmosome proteins. Likewise, Dsp transcript was not detected by quantitative polymerase chain reaction and its protein by Western Blot in the brain tissue (data not shown). Other epithelial cells, such as the gastrointestinal epithelia cells, and vascular pericytes are expected to express CSPG4 and perhaps even the desmosome proteins. In addition, immunofluorescence staining of nonmyocyte cardiac cells showed heterogeneity of the CSPG4 pos cells, a fraction of which also expressed the PDGFRB, a pericyte marker. Deletion of the Dsp gene in such cells and organs might cause concomitant phenotypes, which could confound the findings. However, concomitant phenotypes in organs other than the heart were not discernible at the clinical level, but such organs are not examined in great detail, based on the assumption that unanticipated phenotypes in noncardiac tissues would not directly relate to cardiac arrhythmias and conduction defects in the Cspg4-Cre/Esr1*:Dsp F/F mice. The underpinning mechanism(s) of cardiac arrhythmias in ACM, in general, and early arrhythmias occurring in the presence of a normal left ventricular function, in particular, are not well understood. Desmosomes along with adherens junction are the main constituents of IDs responsible for cellcell attachment structures and mechanotransduction. In the human heart, they assemble into a single structure, localized to the polar regions of cardiac myocytes, referred to as area composite. 48 However, ID proteins are not exclusive to cardiac myocytes but are also expressed in the CCS, including His bundles and Purkinje fibers, which is in keeping with shared embryonic origin of CCS and cardiac myocytes. 24 In contrast to cardiac myocytes, however, the ID proteins are not confined to the polar regions but are rather scattered in cell membrane throughout and involved in lateral cell-cell contacts. 24 In addition to desmosome proteins, the ID protein constituents also include the ion channels, including SCN5A, which is responsible for the Brugada syndrome, long QT3, and familial atrioventricular block. [49] [50] [51] Moreover, conductive proteins, such as GJA5 and Ankyrin G, also localize to the IDs. 52, 53 In accord with these data, CSPG4 pos cells express several proteins, which are constituents of ion channels in the heart and are involved in cardiac arrhythmias, including SCN5A, KCNQ1, KCNH2, and KCNE1. 54 Deficiency of DSP and other desmosome proteins could affect assembly and localization of proteins involved in cardiac conduction affecting the sodium current and conduction velocity and, therefore, predisposing to cardiac conduction defects and arrhythmias. 55, 56 In support of complex interactions between ID protein constituents, mutations in PKP2 have been shown to affect the sodium current and induce a phenotype resembling the Brugada syndrome, likely through interactions with SCN5A. 44 Conversely, mutations in SCN5A have been associated with the arrhythmogenic right ventricular cardiomyopathy-like phenotype. 57 Moreover, deficiency of desmosome proteins, including DSP, is associated with a reduced expression level of GJA5. 58 Thus, the existing data point to intricate and complex interactions between the conduction system and the desmosome proteins in maintaining normal ion current and conduction in the heart.
In conclusion, the data suggest that deletion of Dsp gene in a subset of cardiac nonmyocyte cells and skin keratinocytes, marked by the expression of CSPG4, leads to cardiac arrhythmias, conduction defects, and premature death occurring in the absence of cardiac dysfunction and fibroadiposis, as in the early stages of human ACM. Likewise, it leads to severe palmoplantar keratosis and alopecia, as observed in the cardiocutaneous syndromes in humans. The data also exclude CSPG4 pos cells, which also include a subset of pericytes and neuroglial cells as a cell source of excess fibroadipocytes in ACM. Collectively, the findings indicate multicellular origin of cardiac phenotypes in ACM and provide insights into the pathogenesis of cardiocutaneous syndromes.
